The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,497,442 in first-year total cost, median $748,721.
Most frequent study sections
- Special Emphasis Panel[ZAA1 DD (44)]2
Most frequent institutions
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- TEXAS TECH UNIVERSITY HEALTH SCIS CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Chemically modified minocycline for treatment of alcohol use disorder1U01AA027401-01 | BACKUS, BRITTANY LEILANIBERGESON, SUSAN E.REID, TED W | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, TX | $824,590 | ZAA1 |
| 2018 | A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder1R01AA027399-01 | GRAY, KEVIN MSQUEGLIA, LINDSAY | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $672,852 | ZAA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.